GETTING MY TUSSILAGONE TO WORK

Feasible predictive biomarkers for tumor reaction to mTOR inhibitors, as are described in glioblastoma, breast and prostate most cancers cells, could be the differential expression of mTOR pathway proteins, PTEN, AKT, and S6.[1] So, this knowledge relies on preclinical assays, depending on in vitro cultured tumor cell traces, which recommend that t